The NHS in England plans to provide artificial pancreas systems to patients with Type 1 diabetes.

Over the next five years, the aim is to equip all eligible patients with these systems.

An initial fund of £2.5 million has been dedicated to identifying patients for the program.

Artificial pancreas devices automatically monitor glucose and administer insulin, potentially improving health outcomes and quality of life.

Approximately 300,000 people in England could benefit from the technology.

Following the FDA's first approval of such a system in 2016, there are now multiple artificial pancreas systems in the U.S. market.

The NHS's initiative is a significant move towards better management of Type 1 diabetes in the UK.